Patent Assignment
Reel/Frame 063359/0174
Security Interest
Recorded: 2023-04-18
Pages: 5
Assignor
BIOCRYST PHARMACEUTICALS, INC.
Executed: 2023-04-17
Assignee
ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP
505 FIFTH AVENUE, FLOOR 18, NEW YORK, NEW YORK, 10017
Covered Property
(1)
Plasma Kallikrein Inhibitors and Methods of Use Thereof in Ocular Disorders
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Release of Security Interest
Apr 19, 2023
From: ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 063371/0979 →
Nunc Pro Tunc Assignment
Dec 29, 2025
From: BABU, YARLAGADDA
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 073326/0400 →
Assignment of Assignor's Interest
Dec 29, 2025
From: KANSARA, VIRAL; MCELHENY, RICK
To: CLEARSIDE BIOMEDICAL, INC.
Reel/Frame 073326/0670 →
Assignment of Assignor's Interest
Dec 29, 2025
From: CLEARSIDE BIOMEDICAL, INC.
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 073326/0737 →
Security Interest
Jan 23, 2026
From: BIOCRYST PHARMACEUTICALS, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 074485/0651 →